Group items tagged

Muscle Atrophy Definition - Types - Causes - Treatment

National Institute of Neurological Disordersand Stroke NINDS - Cerebral Atrophy Information Page

American Academy of Neurology - Cerebral Atrophy - Definition - Research

2003 International Federation of Clinical Neurophysiology study to assess the relationship between cerebellum and brain cortical activity without motor factors, we recorded the mid-latency auditory evoked responses (MLRs) with simultaneous recording of the electroencephalography (EEG) at rest in patients with 'pure cortical cerebellar atrophy (CCA)'.

Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats. Hypoxia-ischemia (HI), as a major cause of fetal brain damage, has long-lasting neurological implications. Therefore, therapeutic interventions that attenuate the neuropathological out come of HI while also improving the neurofunctional outcome are of paramount clinical importance. The aim of this study was to investigate the long-term functional and protective actions of granulocyte-colony stimulating factor (G-CSF) treatment in an experimental model of cerebral. RESULTS: Granulocyte-colony stimulation promoted somatic growth and prevented brain atrophy and underdevelopment of the heart in infant rats.

National Library of Medicine - National Institute of Health - PubMed Article Abstract: Floppy infant syndrome - Review - On long-term follow up, cerebral palsy and mental retardation turn out to be the 2 most common causes of FIS. This review focuses on neuromuscular causes of FIS. With the advent of molecular diagnosis, a few conditions can be diagnosed by DNA analysis of the peripheral lymphocytes (myotonic dystrophy, spinal muscular atrophy); however, for the most part, electrodiagnostic studies and muscle biopsy remain as essential diagnostic tools for FIS.

Dedicated to conquering more then 40 neuromuscular diseases that affect a million Americans. Nonprofit health agency dedicated to curing muscular dystrophy, ALS and related diseases by funding worldwide research. Provides comprehensive health care and support services, advocacy and education

Charcot-Marie-Tooth, or CMT, is the most commonly inherited neurological disorder and is found world-wide in all races and ethnic groups. Discovered in 1886 by three physicians, Jean-Martin-Charcot, Pierre Marie, and Howard Henry Tooth, CMT affects an estimated 2.6 million people. The CMTA is a 501(C)(3)nonprofit organization founded in 1983 whose goals are patient support, public education, promotion of research and ultimately the treatment and cure of CMT. This international group of men and women are noted CMT experts in neurology, genetics, orthopedic surgery, physiatry, physical therapy and podiatry.